Trial record 1 of 1 for:    NCT01828346
Previous Study | Return to List | Next Study

Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy

This study is currently recruiting participants.
Verified February 2014 by TetraLogic Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
TetraLogic Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01828346
First received: April 5, 2013
Last updated: February 18, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)